BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 21232048)

  • 21. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c.
    Liu G; Cooley MA; Nair PM; Donovan C; Hsu AC; Jarnicki AG; Haw TJ; Hansbro NG; Ge Q; Brown AC; Tay H; Foster PS; Wark PA; Horvat JC; Bourke JE; Grainge CL; Argraves WS; Oliver BG; Knight DA; Burgess JK; Hansbro PM
    J Pathol; 2017 Dec; 243(4):510-523. PubMed ID: 28862768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting cytokines to treat asthma and chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Immunol; 2018 Jul; 18(7):454-466. PubMed ID: 29626211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymic stromal lymphopoietin (TSLP) and Toluene-diisocyanate-induced airway inflammation: Alleviation by TSLP neutralizing antibody.
    Yu G; Zhang Y; Wang X; Sai L; Bo C; Yeo AJ; Lavin MF; Peng C; Jia Q; Shao H
    Toxicol Lett; 2019 Dec; 317():59-67. PubMed ID: 31577921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th17-mediated inflammation in asthma.
    Newcomb DC; Peebles RS
    Curr Opin Immunol; 2013 Dec; 25(6):755-60. PubMed ID: 24035139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma: the importance of dysregulated barrier immunity.
    Lambrecht BN; Hammad H
    Eur J Immunol; 2013 Dec; 43(12):3125-37. PubMed ID: 24165907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease.
    Holgate ST
    Cytokine; 2004 Nov 21-Dec 7; 28(4-5):152-7. PubMed ID: 15588688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
    Lordan JL; Bucchieri F; Richter A; Konstantinidis A; Holloway JW; Thornber M; Puddicombe SM; Buchanan D; Wilson SJ; Djukanović R; Holgate ST; Davies DE
    J Immunol; 2002 Jul; 169(1):407-14. PubMed ID: 12077271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine targets in airway inflammation.
    Schuijs MJ; Willart MA; Hammad H; Lambrecht BN
    Curr Opin Pharmacol; 2013 Jun; 13(3):351-61. PubMed ID: 23643194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual cytokines contributing to asthma pathophysiology: valid targets for asthma therapy?
    Chung KF
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1320-6. PubMed ID: 14758771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cytokines and cytokine-producing T cells in allergic disorders.
    Wisniewski JA; Borish L
    Allergy Asthma Proc; 2011; 32(2):83-94. PubMed ID: 21439160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals.
    Heck S; Nguyen J; Le DD; Bals R; Dinh QT
    Int Arch Allergy Immunol; 2015; 168(4):241-52. PubMed ID: 26895179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine antagonists for the treatment of asthma: progress to date.
    Antoniu SA
    BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function.
    Ghonim MA; Pyakurel K; Ibba SV; Al-Khami AA; Wang J; Rodriguez P; Rady HF; El-Bahrawy AH; Lammi MR; Mansy MS; Al-Ghareeb K; Ramsay A; Ochoa A; Naura AS; Boulares AH
    J Transl Med; 2015 Jul; 13():225. PubMed ID: 26169874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antialarmins for treatment of asthma: future perspectives.
    Al-Sajee D; Oliveria JP; Sehmi R; Gauvreau GM
    Curr Opin Pulm Med; 2018 Jan; 24(1):32-41. PubMed ID: 29084017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma.
    Lin SC; Shi LS; Ye YL
    Cells; 2019 Jul; 8(7):. PubMed ID: 31284537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic stromal lymphopoietin: a central regulator of allergic asthma.
    Watson B; Gauvreau GM
    Expert Opin Ther Targets; 2014 Jul; 18(7):771-85. PubMed ID: 24930783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand.
    Huang L; Zhang X; Wang M; Chen Z; Yan Y; Gu W; Tan J; Jiang W; Ji W
    Pathobiology; 2019; 86(2-3):111-117. PubMed ID: 30408778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cytokines of Asthma.
    Lambrecht BN; Hammad H; Fahy JV
    Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients.
    Truyen E; Coteur L; Dilissen E; Overbergh L; Dupont LJ; Ceuppens JL; Bullens DM
    Thorax; 2006 Mar; 61(3):202-8. PubMed ID: 16449261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-12: potential role in asthma therapy.
    Leonard P; Sur S
    BioDrugs; 2003; 17(1):1-7. PubMed ID: 12534316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.